CanSino Biologics Inc. revenue breakdown overview

CanSino Biologics Inc. revenue for the last year amounted to 44.05 M EUR, the most of which — 45.77 M EUR — came from its highest performing source at the moment, Vaccine Products, the year earlier bringing 143.90 M EUR. The greatest contribution to the revenue figure was made by China — last year it brought CanSino Biologics Inc. 43.84 M EUR, and the year before that — 113.05 M EUR.